Sharon Henderson

As First Industrial Realty Trust preps its Q2 report, its performance is more than numbers—it's a barometer for supply chain resilience and market discipline.

New long-term data shows a 60-day nerve stimulation treatment helps 8 in 10 patients avoid surgery, challenging the entire strategy for chronic pain.

A new partnership between Cynet and Pax8 isn't just another deal. It is a calculated move to arm MSPs against fragmented defenses and complex cyber threats.

AstraZeneca's new deal with genomics firm Helix isn't just a partnership; it's a bet on a future where drug discovery is driven by massive data vaults.

As foldable phones and tablets flood the market, their returns create a costly logistical nightmare. A new robotic system reveals a deeper strategy to master the circular economy.

A new packaging innovation offers a path to sustainability without the operational headaches, signaling a systemic shift in how we handle e-commerce waste.

iPower Inc. secured $2M to fund a pivot into AI, but a closer look reveals a company battling financial headwinds while making a risky bet on its future.

After a Health Canada-mandated pause, LSL's Steri-Med is near full remediation. This is more than a fix—it’s a calculated play for North American market leadership.

Philips Evnia's new monitor isn't just hardware; it's a strategic play to end the gamer's dilemma. Can one screen truly master both speed and spectacle?

Sandisk's latest 3D NAND memory isn't just a tech upgrade. It's a strategic move in the high-stakes battle to power the AI revolution. Here's why.

Roc Nation and Paramount+ aren't just streaming a historic concert. They are testing the future of national celebrations and redefining the flow of cultural power.

Xeltis's bioabsorbable aXess graft hits a major US trial milestone, signaling a strategic shift in renal care away from failing synthetics to living tissue.

Molecular Partners and Orano Med begin human trials for a novel radiopharmaceutical, hoping to unlock a new front against small cell lung cancer.

The Hawaiian Native Corporation's defense contracting arm, formerly DAWSON, is now LAUKOA. It's more than a new logo; it's a calculated move in a high-stakes game.

Dallas's Carter Arnett rebrands, elevating two elite women litigators. It's more than a name change—it's a strategic play for dominance in high-stakes law.

As AI agents proliferate, they remain isolated. Fulcra Dynamics' new infrastructure gives them a shared, secure memory, a crucial step toward true AI collaboration.

The National Kidney Foundation's new chief brings a personal mission and a history of strategic innovation to confront a silent, multi-billion-dollar crisis.

Vyome Holdings secures a key patent in China, not by betting the farm, but by making a shrewd, capital-efficient move to tap into a massive future market.

The commodities giant's move from London to Bermuda is more than a change of address. It's a strategic play to simplify, cut costs, and align with US markets.

Ecovyst's quiet acquisition of Calabrian is more than a line item. It's a calculated pivot from a niche acid supplier to a diversified sulfur chemistry powerhouse.